125 related articles for article (PubMed ID: 23845778)
61. Fanconi anaemia research: current status and prospects.
Joenje H; Mathew C; Gluckman E
Eur J Cancer; 1995; 31A(2):268-72. PubMed ID: 7718336
[TBL] [Abstract][Full Text] [Related]
62. Mouse models of Fanconi anemia.
Parmar K; D'Andrea A; Niedernhofer LJ
Mutat Res; 2009 Jul; 668(1-2):133-40. PubMed ID: 19427003
[TBL] [Abstract][Full Text] [Related]
63. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
[TBL] [Abstract][Full Text] [Related]
64. Impaired immune function in children and adults with Fanconi anemia.
Myers KC; Sauter S; Zhang X; Bleesing JJ; Davies SM; Wells SI; Mehta PA; Kumar A; Marmer D; Marsh R; Brown D; Butsch Kovacic M
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28557197
[TBL] [Abstract][Full Text] [Related]
65. Upregulated LINE-1 Activity in the Fanconi Anemia Cancer Susceptibility Syndrome Leads to Spontaneous Pro-inflammatory Cytokine Production.
Brégnard C; Guerra J; Déjardin S; Passalacqua F; Benkirane M; Laguette N
EBioMedicine; 2016 Jun; 8():184-194. PubMed ID: 27428429
[TBL] [Abstract][Full Text] [Related]
66. Fanconi anemia cell lines deficient in alphaII spectrin express normal levels of alphaII spectrin mRNA.
Lefferts JA; Lambert MW
Biochem Biophys Res Commun; 2003 Aug; 307(3):510-5. PubMed ID: 12893251
[TBL] [Abstract][Full Text] [Related]
67. A small molecule p53 activator attenuates Fanconi anemia leukemic stem cell proliferation.
Du W; Li X; Wilson AF; Pang Q
Stem Cell Res Ther; 2018 May; 9(1):145. PubMed ID: 29784053
[TBL] [Abstract][Full Text] [Related]
68. Fanconi anemia genes are highly expressed in primitive CD34+ hematopoietic cells.
Aubé M; Lafrance M; Brodeur I; Delisle MC; Carreau M
BMC Blood Disord; 2003 Jun; 3(1):1. PubMed ID: 12809565
[TBL] [Abstract][Full Text] [Related]
69. Expression Profiling of Differentially Regulated Genes in Fanconi Anemia.
Zipporah E B; Govarthanan K; Shyamsunder P; Verma RS
Methods Mol Biol; 2018; 1783():243-258. PubMed ID: 29767366
[TBL] [Abstract][Full Text] [Related]
70. Fanconi anemia pathway defects in inherited and sporadic cancers.
Chen H; Zhang S; Wu Z
Transl Pediatr; 2014 Oct; 3(4):300-4. PubMed ID: 26835350
[TBL] [Abstract][Full Text] [Related]
71. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
Tischkowitz M; Ameziane N; Waisfisz Q; De Winter JP; Harris R; Taniguchi T; D'Andrea A; Hodgson SV; Mathew CG; Joenje H
Br J Haematol; 2003 Nov; 123(3):469-71. PubMed ID: 14617007
[TBL] [Abstract][Full Text] [Related]
72. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
Sebert M; Gachet S; Leblanc T; Rousseau A; Bluteau O; Kim R; Ben Abdelali R; Sicre de Fontbrune F; Maillard L; Fedronie C; Murigneux V; Bellenger L; Naouar N; Quentin S; Hernandez L; Vasquez N; Da Costa M; Prata PH; Larcher L; de Tersant M; Duchmann M; Raimbault A; Trimoreau F; Fenneteau O; Cuccuini W; Gachard N; Auger N; Tueur G; Blanluet M; Gazin C; Souyri M; Langa Vives F; Mendez-Bermudez A; Lapillonne H; Lengline E; Raffoux E; Fenaux P; Adès L; Forcade E; Jubert C; Domenech C; Strullu M; Bruno B; Buchbinder N; Thomas C; Petit A; Leverger G; Michel G; Cavazzana M; Gluckman E; Bertrand Y; Boissel N; Baruchel A; Dalle JH; Clappier E; Gilson E; Deriano L; Chevret S; Sigaux F; Socié G; Stoppa-Lyonnet D; de Thé H; Antoniewski C; Bluteau D; Peffault de Latour R; Soulier J
Cell Stem Cell; 2023 Feb; 30(2):153-170.e9. PubMed ID: 36736290
[TBL] [Abstract][Full Text] [Related]
73. Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia.
Solanki A; Rajendran A; Mohan S; Raj R; Vundinti BR
PLoS One; 2020; 15(1):e0227603. PubMed ID: 31940411
[TBL] [Abstract][Full Text] [Related]
74. Impact of Epigenetics on Complications of Fanconi Anemia: The Role of Vitamin D-Modulated Immunity.
Velleuer E; Carlberg C
Nutrients; 2020 May; 12(5):. PubMed ID: 32397406
[TBL] [Abstract][Full Text] [Related]
75. The Fanconi anemia group C protein interacts with uncoordinated 5A and delays apoptosis.
Huang F; Ben Aissa M; Magron A; Huard CC; Godin C; Lévesque G; Carreau M
PLoS One; 2014; 9(3):e92811. PubMed ID: 24676280
[TBL] [Abstract][Full Text] [Related]
76. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
[TBL] [Abstract][Full Text] [Related]
77. A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites.
de Vries Y; Lwiwski N; Levitus M; Kuyt B; Israels SJ; Arwert F; Zwaan M; Greenberg CR; Alter BP; Joenje H; Meijers-Heijboer H
Anemia; 2012; 2012():865170. PubMed ID: 22701786
[TBL] [Abstract][Full Text] [Related]
78. Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.
Panneerselvam J; Xie G; Che R; Su M; Zhang J; Jia W; Fei P
J Proteome Res; 2016 Apr; 15(4):1333-41. PubMed ID: 26956768
[TBL] [Abstract][Full Text] [Related]
79. Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia.
Enache A; Sajjad B; Altintas B; Giri N; McReynolds LJ
Fam Cancer; 2024 Jun; ():. PubMed ID: 38907138
[TBL] [Abstract][Full Text] [Related]
80. Proteomic profiling and bioinformatics analysis identify key regulators during the process from fanconi anemia to acute myeloid leukemia.
Hou H; Li D; Gao J; Gao L; Lu Q; Hu Y; Wu S; Chu X; Yao Y; Wan L; Ling J; Pan J; Xu G; Hu S
Am J Transl Res; 2020; 12(4):1415-1427. PubMed ID: 32355551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
